Literature DB >> 23364815

Opiate agonists and antagonists modulate taste perception in opiate-maintained and recently detoxified subjects.

Amy Green1, Arun Kaul, Jacinta O'Shea, Ekta Sharma, Lisa Bennett, Emma L Mullings, Marcus R Munafò, David J Nutt, Jan K Melichar, Lucy F Donaldson.   

Abstract

Heroin addicts consume large quantities of refined sugars. This study investigated the effect of opiate use and antagonism on sweet taste in opiate-maintained drug users and detoxified former chronic opiate users, using a within-subject design. Seven opiate users received methadone and seven buprenorphine maintenance. Six detoxified subjects received naltrexone. Sucrose recognition thresholds and measurements of pleasantness and intensity were determined before and four hours after 1) a single dose of methadone or buprenorphine or 2) naltrexone. Control data were taken from a cohort of healthy volunteers including smokers. All measures of sweet and salt taste perception were significantly greater in opiate users and recently detoxified subjects compared to control subjects, with the exception of sweet pleasantness, which returned to control level after detoxification. Acute methadone administration reduced salt thresholds and unpleasantness to control levels. Increased sweet thresholds and salt unpleasantness in detoxified subjects were reversed by acute opioid antagonism, returning to control levels. These results suggest that opiate use and antagonism alters taste perception. Some of the alterations reverse on detoxification (sweet pleasantness), and others can be reversed by opioid antagonism (sweet threshold, salt unpleasantness). Changes in taste perception may underlie altered consumption of refined sugars in opiate users.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23364815     DOI: 10.1177/0269881112472567

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  11 in total

1.  Sustained opioid antagonism modulates striatal sensitivity to baby schema in opioid use disorder.

Authors:  An-Li Wang; Steven B Lowen; Igor Elman; Zhenhao Shi; Victoria P Fairchild; Alexander Bouril; Ruben C Gur; Daniel D Langleben
Journal:  J Subst Abuse Treat       Date:  2017-10-18

2.  Associations between opioid dependence and sweet taste preference.

Authors:  Joshua B B Garfield; Dan I Lubman
Journal:  Psychopharmacology (Berl)       Date:  2021-02-01       Impact factor: 4.530

3.  Naltrexone alters the processing of social and emotional stimuli in healthy adults.

Authors:  Margaret C Wardle; Anya K Bershad; Harriet de Wit
Journal:  Soc Neurosci       Date:  2016-01-22       Impact factor: 2.083

4.  Feeding Releases Endogenous Opioids in Humans.

Authors:  Jetro J Tuulari; Lauri Tuominen; Femke E de Boer; Jussi Hirvonen; Semi Helin; Pirjo Nuutila; Lauri Nummenmaa
Journal:  J Neurosci       Date:  2017-07-26       Impact factor: 6.167

5.  Heroin and saccharin demand and preference in rats.

Authors:  Lindsay P Schwartz; Jung S Kim; Alan Silberberg; David N Kearns
Journal:  Drug Alcohol Depend       Date:  2017-06-13       Impact factor: 4.492

Review 6.  Opioid system and human emotions.

Authors:  Lauri Nummenmaa; Lauri Tuominen
Journal:  Br J Pharmacol       Date:  2017-05-24       Impact factor: 8.739

Review 7.  Opioids and Acute Kidney Injury.

Authors:  Mary Mallappallil; Siddhartha Bajracharya; Moro Salifu; Ernie Yap
Journal:  Semin Nephrol       Date:  2021-01       Impact factor: 4.472

Review 8.  Interventions for managing taste disturbances.

Authors:  Sumanth Kumbargere Nagraj; Renjith P George; Naresh Shetty; David Levenson; Debra M Ferraiolo; Ashish Shrestha
Journal:  Cochrane Database Syst Rev       Date:  2017-12-20

9.  Metabolic and Addiction Indices in Patients on Opioid Agonist Medication-Assisted Treatment: A Comparison of Buprenorphine and Methadone.

Authors:  Igor Elman; Margaret Howard; Jacob T Borodovsky; David Mysels; David Rott; David Borsook; Mark Albanese
Journal:  Sci Rep       Date:  2020-03-27       Impact factor: 4.379

Review 10.  The Role of Mu-Opioids for Reward and Threat Processing in Humans: Bridging the Gap from Preclinical to Clinical Opioid Drug Studies.

Authors:  Isabell M Meier; Marie Eikemo; Siri Leknes
Journal:  Curr Addict Rep       Date:  2021-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.